Netpharm Consulting ApS: Financial statements 2024
CVR: 41104554
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Netpharm Consulting ApS (CVR 41104554) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -14,288 and a net result of DKK -14,288 compared with DKK -19,807 the year before. Equity in the 2024 report amounted to DKK 33,706. The solvency ratio was 100%.
- Gross Profit
- DKK -14,288
- Profit/Loss
- DKK -14,288
- Equity
- DKK 33,706
- Total Assets
- DKK 33,706
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -14K | -14K | 34K | 0 |
| 2023 | - | -20K | -20K | 48K | - |
| 2022 | - | - | -10K | 68K | - |
| 2021 | 153K | 200 | 200 | 78K | - |
| 2020 | 0 | -12K | -12K | 28K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Netpharm Consulting ApS has published its annual report for 2023. Gross profit came to DKK -19,807, and the net result was DKK -19,807.
About Netpharm Consulting ApS
Netpharm Consulting ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Byong Sandersen. The company is owned by Netpharm Holding ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,341 and a net result of DKK -18,341 compared with DKK -14,288 the year before. Equity in the 2025 report amounted to DKK 15,365.